200 related articles for article (PubMed ID: 6191336)
21. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
Galvin MJ; Lefer AM
Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
[No Abstract] [Full Text] [Related]
22. [The significance of humoral factors for the course and prognosis of septic infections].
Hockerts T; Trenkel K; Sieber J
Z Kinderchir; 1982 Nov; 37(3):82-9. PubMed ID: 7180205
[No Abstract] [Full Text] [Related]
23. Characteristics of shock-induced circulating cardiodepressant substances: a brief review.
Goldfarb RD
Circ Shock Suppl; 1979; 1():23-33. PubMed ID: 111872
[No Abstract] [Full Text] [Related]
24. Reticuloendothelial system and neuro-endocrine stimulation in shock therapy.
Altura BM
Adv Shock Res; 1980; 3():3-25. PubMed ID: 7030014
[No Abstract] [Full Text] [Related]
25. [Myocardial depressant factor in shock].
Okada K; Kosugi I; Yamaguchi Y; Innami H; Kawashima Y
Masui; 1973 May; 22(5):414-22. PubMed ID: 4737987
[No Abstract] [Full Text] [Related]
26. [General biological basis of reaction to aggression].
Laborit H
Agressologie; 1972; 13(1):1-54. PubMed ID: 5073653
[No Abstract] [Full Text] [Related]
27. The lysosomal protease--myocardial depressant factor system in circulatory shock.
Lefer AM; Glenn TM
Adv Exp Med Biol; 1972; 33(0):367-73. PubMed ID: 4672015
[No Abstract] [Full Text] [Related]
28. Myocardial depressant factor in cardiogenic shock.
Hosono K; Okuda M
Am Heart J; 1976 Jan; 91(1):126-8. PubMed ID: 1244714
[No Abstract] [Full Text] [Related]
29. Use of glucocorticoids in shock.
Yamamura H; Kosugi I; Okada K
Prog Clin Biol Res; 1983; 111():229-41. PubMed ID: 6346329
[No Abstract] [Full Text] [Related]
30. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
[No Abstract] [Full Text] [Related]
31. Current concepts on myocardial depressant factor.
Giuseppe T; Marco S; Sigfrido I; Pasquale M; Giorgio C
Mater Med Pol; 1989; 21(1):53-6. PubMed ID: 2699345
[TBL] [Abstract][Full Text] [Related]
32. [Various clinical considerations on shock].
Cattaneo AD
Minerva Anestesiol; 1970 Dec; 36(12):762-7. PubMed ID: 5314144
[No Abstract] [Full Text] [Related]
33. Protective actions of nafazatrom in traumatic shock.
Lefer AM; Messenger M
Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
[TBL] [Abstract][Full Text] [Related]
34. [Endogenous shock substances: research trends].
Okada K
Nihon Rinsho; 1980; 38(4):1836-42. PubMed ID: 7411893
[No Abstract] [Full Text] [Related]
35. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality.
Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L
J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768
[TBL] [Abstract][Full Text] [Related]
36. [Effects of steroids on circulatory shock and mechanisms of action (author's transl)].
Altura BA
Masui; 1980 Apr; 29(4):305-16. PubMed ID: 6991734
[No Abstract] [Full Text] [Related]
37. Metabolic aspects of shock.
Schumer W
Surg Annu; 1974; 6():1-16. PubMed ID: 4139771
[No Abstract] [Full Text] [Related]
38. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
Curtis MT; Lefer AM
Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
[TBL] [Abstract][Full Text] [Related]
39. Actions of dopamine in splanchnic artery occlusion shock.
Galvin MJ; Lefer AM
Am J Physiol; 1978 Jan; 234(1):H1-6. PubMed ID: 623270
[No Abstract] [Full Text] [Related]
40. Myocardial depression in septic shock: physiologic and metabolic effects of a plasma factor on an isolated heart.
Maksad AK; Cha CJ; Stuart RC; Brosco FA; Clowes GH
Surg Forum; 1978; 29():23-5. PubMed ID: 401143
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
